COVID-19 insurance sales surge in Japan


Sales of life insurance products related to COVID-19 have reportedly surged in Japan, as the public is worried about the negative financial effects caused by contracting the disease.

According to a report by The Japan Times, Taiyo Life Insurance Co. has said that sales of its COVID-19 insurance product, released in September 2020, have exceeded 100,000 policies, the fastest product from the insurer to reach that mark over the past 10 years.

The insurance product will provide a lump sum of up to ¥400,000 (SG$4,920) for hospital stays or home recovery, in case the policyholder is infected by the coronavirus.

Earlier this month, Dai-Ichi Life Insurance Co. launched a product that will pay out ¥100,000 if the policyholder is diagnosed with COVID-19. The policy’s premium changes per month, depending on the number of infections in Japan.

In the week since the product’s launch, Dai-Ichi said it has sold around 3,000 policies.

Another insurer, Fukoku Mutual Life Insurance Co., launched in December 2020 a medical insurance product that will double its lump sum payments for no additional charge if the policyholder is hospitalised due to COVID-19 or other infections diseases.

Akio Negishi, chairman of the Life Insurance Association of Japan and president of Meiji Yasuda Life Insurance Co., told The Japan Times that it is a positive sign for the life insurance industry that insurers are developing a wide variety of products to address the public’s needs.

Source Article

Next Post

European Central Bank reports weak lending in Eurozone

According to the European Central Bank, demand for business loans in the eurozone fell and banks tightened credit standards in Q1 of 2021, a toxic combination that challenges the bloc’s slow economic recovery from the pandemic. European Central Bank reports weak lending in Eurozone dampening recovery The Central Bank’s latest lending […]